ped a reputation for innovation, using Web 2.0 technologies to foster new forms of scientific communication and collaboration. Examples include the social bookmarking service Connotea, which enables researchers to share, find, and organize articles of interest. Meanwhile, NPG's professional networking website for scientists, Nature Network
, helps scientists to meet, communicate and collaborate.
NPG is a global company with principal offices in London, New York and Tokyo and offices in Basingstoke, Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Melbourne, Munich, Paris, San Francisco, Seoul and Washington DC. For more information, please go to www.nature.com.
Founded in 2001, InnoCentive built the first global web community for open innovation, enabling scientists, engineers, professionals and entrepreneurs to collaborate to deliver breakthrough solutions for R&D-driven organizations. InnoCentive Seekers, who collectively spend billions of dollars on R&D, submit complex problems to the InnoCentive Marketplace where more than 170,000 engineers, scientists, inventors, business people, and research organizations in more than 175 countries are invited to solve them. Solvers who deliver the most innovative solutions receive financial awards ranging up to US$1,000,000. InnoCentive's Seekers include commercial, government and non-profit organizations such as Avery Dennison, Procter & Gamble, Pendulum, Eli Lilly and Company, Janssen, Solvay, SAP and The Rockefeller Foundation.
For more information on InnoCentive, go to: www.innocentive.com.
InnoCentive and InnoCentive Challenge are registered trademarks of InnoCentive, Inc. Other product or service names mentioned herein are the trademarks of their respective owners.
FoPage: 1 2 3 4 Related medicine technology :1
. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells2
. Brain Signature for Cigarette Cravings Identified3
. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics4
. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells5
. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling6
. InVitrias Cellastim Showcased in Nature Article7
. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease8
. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership9
. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery10
. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign11
. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups